Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663

Watchlist Manager
Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Watchlist
Price: 23.32 INR -0.81%
Market Cap: 1B INR
Have any thoughts about
Bharat Immunologicals and Biologicals Corporation Ltd?
Write Note
BIBCL
/
Income Statement
/
Cost of Revenue

Bharat Immunologicals and Biologicals Corporation Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bharat Immunologicals and Biologicals Corporation Ltd
Cost of Revenue Peer Comparison

Comparables:
526139
Z
532039
HESTERBIO
BIOCON
PANACEABIO

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Cost of Revenue
-₹218.1m
CAGR 3-Years
37%
CAGR 5-Years
8%
CAGR 10-Years
17%
Transgene Biotek Ltd
BSE:526139
Cost of Revenue
-₹5.4k
CAGR 3-Years
79%
CAGR 5-Years
63%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Cost of Revenue
-₹711k
CAGR 3-Years
-30%
CAGR 5-Years
36%
CAGR 10-Years
38%
Hester Biosciences Ltd
NSE:HESTERBIO
Cost of Revenue
-₹901.3m
CAGR 3-Years
-11%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Cost of Revenue
-₹49.3B
CAGR 3-Years
-28%
CAGR 5-Years
-21%
CAGR 10-Years
-15%
Panacea Biotec Ltd
NSE:PANACEABIO
Cost of Revenue
-₹2.2B
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
N/A

See Also

What is Bharat Immunologicals and Biologicals Corporation Ltd's Cost of Revenue?
Cost of Revenue
-218.1m INR

Based on the financial report for Sep 30, 2023, Bharat Immunologicals and Biologicals Corporation Ltd's Cost of Revenue amounts to -218.1m INR.

What is Bharat Immunologicals and Biologicals Corporation Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
17%

Over the last year, the Cost of Revenue growth was 72%. The average annual Cost of Revenue growth rates for Bharat Immunologicals and Biologicals Corporation Ltd have been 37% over the past three years , 8% over the past five years , and 17% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 198,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.